These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the Astvad KMT; Sanglard D; Delarze E; Hare RK; Arendrup MC Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224538 [No Abstract] [Full Text] [Related]
24. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222 [TBL] [Abstract][Full Text] [Related]
25. Investigating Antifungal Susceptibility in Delavy M; Dos Santos AR; Heiman CM; Coste AT Front Cell Infect Microbiol; 2019; 9():19. PubMed ID: 30792970 [TBL] [Abstract][Full Text] [Related]
26. Stable isotope labeling as a promising tool for rapid drug susceptibility testing in Neisseria gonorrhoeae. Dadwal R; Paul S; Gupta P; Yadav R; Sood S; Ghosh AK; Shivaprakash MR; Gainder S; Sethi S Braz J Microbiol; 2023 Sep; 54(3):1819-1825. PubMed ID: 37258877 [TBL] [Abstract][Full Text] [Related]
27. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata. Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820 [TBL] [Abstract][Full Text] [Related]
28. Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries. Arastehfar A; Daneshnia F; Kord M; Roudbary M; Zarrinfar H; Fang W; Hashemi SJ; Najafzadeh MJ; Khodavaisy S; Pan W; Liao W; Badali H; Rezaie S; Zomorodian K; Hagen F; Boekhout T Front Cell Infect Microbiol; 2019; 9():21. PubMed ID: 30828570 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study. Liu WL; Huang YT; Hsieh MH; Hii IM; Lee YL; Ho MW; Liu CE; Chen YH; Wang FD Int J Antimicrob Agents; 2019 Feb; 53(2):185-189. PubMed ID: 30722962 [TBL] [Abstract][Full Text] [Related]
30. Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping. Kwon YJ; Shin JH; Byun SA; Choi MJ; Won EJ; Lee D; Lee SY; Chun S; Lee JH; Choi HJ; Kee SJ; Kim SH; Shin MG J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30728190 [No Abstract] [Full Text] [Related]
31. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay. Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227 [TBL] [Abstract][Full Text] [Related]
32. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. Yang YL; Cheng HH; Ho YA; Hsiao CF; Lo HJ J Microbiol Immunol Infect; 2003 Sep; 36(3):187-91. PubMed ID: 14582563 [TBL] [Abstract][Full Text] [Related]
33. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Prakash A; Sharma C; Singh A; Kumar Singh P; Kumar A; Hagen F; Govender NP; Colombo AL; Meis JF; Chowdhary A Clin Microbiol Infect; 2016 Mar; 22(3):277.e1-9. PubMed ID: 26548511 [TBL] [Abstract][Full Text] [Related]
34. Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China. Wu JY; Guo H; Wang HM; Yi GH; Zhou LM; He XW; Zhang Y; Xu J Sci Rep; 2017 Feb; 7():42537. PubMed ID: 28186162 [TBL] [Abstract][Full Text] [Related]
35. [A comparison of the costs, reliability and time of result periods of widely used methods, new molecular methods and MALDI TOF-MS in the routine diagnosis of Candida strains]. Kal Çakmaklıoğulları E; Aşgın N; Değerli K Mikrobiyol Bul; 2019 Apr; 53(2):204-212. PubMed ID: 31130124 [TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study. Lei J; Xu J; Wang T J Mycol Med; 2018 Jun; 28(2):310-313. PubMed ID: 29685520 [TBL] [Abstract][Full Text] [Related]
37. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance]. Karabıçak N; Alem N Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336 [TBL] [Abstract][Full Text] [Related]
38. Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis. Tan L; Bai L; Wang L; He L; Li G; Du W; Shen T; Xiang Z; Wu J; Liu Z; Hu M Microbiol Res; 2018 Nov; 216():120-128. PubMed ID: 30269852 [TBL] [Abstract][Full Text] [Related]
39. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometric identification and antifungal susceptibility analysis of Candida species isolated from patients with invasive yeast infections in five university hospitals. Hu Z; Zhang J; Chen Z; Jin Z; Leng P; Zhou J; Xie X Braz J Microbiol; 2019 Jan; 50(1):99-105. PubMed ID: 30637643 [TBL] [Abstract][Full Text] [Related]